| COPD/post-TB | COPD/tobacco | Control | p |
---|---|---|---|---|
Age | 40 ± 2.1 | 63 ± 10.45 | 43 ± 12.38 | 0.0002 |
Male | 16 (40%) | 42 (84%) | 40 (66.7%) | 0.002 |
Female | 24 (60%) | 8 (16%) | 20 (33.3%) | |
FEV1 | 53.30% (± 17.21%) | 36.88% (± 14.95%) | 83 ± 6.56% | <  0.0001 |
FVC | 84.89 ± 15,1% | 72.97 ± 14.5% | 97.64 ± 4.15% | <  0.0001 |
FEV1/FVC | 62.79% (± 17.95%) | 50.54% (± 12.09%). | 85 ± 6.06% | <  0.0001 |
Stage of disease | Stage I: 0 | Stage I: 0 | Â | 0.038 |
Stage II: 20 (50%) | Stage II: 11 (22%) | |||
Stage III: 15 (37.5%) | Stage III: 14 (28%) | |||
Stage IV: 5 (12.5%) | Stage IV: 25 (50%) |